Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Metz

Showing results (111-120 of 258) with videos related to

Pageof 26
Sort By:
International Journal for Parasitology|March 29, 2013
The effects of Fasciola hepatica tegumental antigens on mast cell functionKrisztina V Vukman, Paul N Adams, David Dowling, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 13, 2018
Nutzen von Mepolizumab bei einer Patientin mit chronischer spontaner UrtikariaMarkus Magerl, Dorothea Terhorst, Martin Metz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 27, 2018
Benefit of mepolizumab treatment in a patient with chronic spontaneous urticariaMarkus Magerl, Dorothea Terhorst, Martin Metz, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2009
Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticariaMartin Metz, Ana Giménez-Arnau, Elena Borzova, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 8, 2019
The response to treatment in chronic spontaneous urticaria depends on how it is measuredKarsten Weller, Martin K Church, Martin Metz, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 10, 2011
Mast cells cultured from IL-3-treated mice show impaired responses to bacterial antigen stimulationKrisztina V Vukman, Tamás Visnovitz, Paul N Adams, et al.
Dermatology and Therapy|November 23, 2015
Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients' Quality of Life: a Prospective, Non-interventional TrialMartin Metz, Karsten Weller, Claudia Neumeister, et al.
Acta Dermato-Venereologica|August 31, 2017
Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical AprepitantTatevik Ohanyan, Nicole Schoepke, Stefan Eirefelt, et al.
Journal of the American Academy of Dermatology|March 22, 2019
Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trialSonja Ständer, Paul Kwon, Joe Hirman, et al.
Journal of Immunological Methods|July 20, 2014
A novel method to generate and culture human mast cells: Peripheral CD34+ stem cell-derived mast cells (PSCMCs)Oliver Schmetzer, Patricia Valentin, Anna Smorodchenko, et al.
Pageof 26

Showing results (111-120 of 258) with videos related to

Sort By:
Pageof 26
International Journal for Parasitology|March 29, 2013
The effects of Fasciola hepatica tegumental antigens on mast cell functionKrisztina V Vukman, Paul N Adams, David Dowling, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 13, 2018
Nutzen von Mepolizumab bei einer Patientin mit chronischer spontaner UrtikariaMarkus Magerl, Dorothea Terhorst, Martin Metz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 27, 2018
Benefit of mepolizumab treatment in a patient with chronic spontaneous urticariaMarkus Magerl, Dorothea Terhorst, Martin Metz, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2009
Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticariaMartin Metz, Ana Giménez-Arnau, Elena Borzova, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 8, 2019
The response to treatment in chronic spontaneous urticaria depends on how it is measuredKarsten Weller, Martin K Church, Martin Metz, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 10, 2011
Mast cells cultured from IL-3-treated mice show impaired responses to bacterial antigen stimulationKrisztina V Vukman, Tamás Visnovitz, Paul N Adams, et al.
Dermatology and Therapy|November 23, 2015
Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients' Quality of Life: a Prospective, Non-interventional TrialMartin Metz, Karsten Weller, Claudia Neumeister, et al.
Acta Dermato-Venereologica|August 31, 2017
Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical AprepitantTatevik Ohanyan, Nicole Schoepke, Stefan Eirefelt, et al.
Journal of the American Academy of Dermatology|March 22, 2019
Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trialSonja Ständer, Paul Kwon, Joe Hirman, et al.
Journal of Immunological Methods|July 20, 2014
A novel method to generate and culture human mast cells: Peripheral CD34+ stem cell-derived mast cells (PSCMCs)Oliver Schmetzer, Patricia Valentin, Anna Smorodchenko, et al.
Pageof 26